Cited by

• Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL-MRI: proof of concept.

  Scott CJ, Jiao J, Melbourne A, Burgos N, Cash DM, De Vita E, Markiewicz PJ, O'Connor A, Thomas DL, Weston PS, Schott JM, Hutton BF, Ourselin S. Scott CJ, et al. J Cereb Blood Flow Metab. 2019 Dec;39(12):2419-2432. doi: 10.1177/0271678X18797343. Epub 2018 Sep 5. J Cereb Blood Flow Metab. 2019. PMID: 30182792 Free PMC article.
• Quantitative Measurement of Tau Burden in a Dual-Time-Window Dynamic PET Imaging Protocol with [¹⁸F]MK6240.

  Xia Y, Dhaynaut M, Chemli Y, Lois C, Hanseeuw BJ, Thibault E, Groot C, Ossenkoppele R, Johnson K, El Fakhri G, Normandin MD, Guehl NJ. Xia Y, et al. J Nucl Med. 2025 Aug 1;66(8):1299-1306. doi: 10.2967/jnumed.125.270165. J Nucl Med. 2025. PMID: 40533354 Free PMC article.
• Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.

  Constantinescu CC, Coleman RA, Pan ML, Mukherjee J. Constantinescu CC, et al. Synapse. 2011 Aug;65(8):778-87. doi: 10.1002/syn.20904. Epub 2011 Mar 21. Synapse. 2011. PMID: 21218455 Free PMC article.
• Quantitative Brain Amyloid PET.

  Jagust WJ, Mattay VS, Krainak DM, Wang SJ, Weidner LD, Hofling AA, Koo H, Hsieh P, Kuo PH, Farrar G, Marzella L. Jagust WJ, et al. J Nucl Med. 2024 May 1;65(5):670-678. doi: 10.2967/jnumed.123.265766. J Nucl Med. 2024. PMID: 38514082 Free PMC article.
• Pharmacokinetic Evaluation of the Tau PET Radiotracer ¹⁸F-T807 (¹⁸F-AV-1451) in Human Subjects.

  Wooten DW, Guehl NJ, Verwer EE, Shoup TM, Yokell DL, Zubcevik N, Vasdev N, Zafonte RD, Johnson KA, El Fakhri G, Normandin MD. Wooten DW, et al. J Nucl Med. 2017 Mar;58(3):484-491. doi: 10.2967/jnumed.115.170910. Epub 2016 Sep 22. J Nucl Med. 2017. PMID: 27660144 Free PMC article.